Quit Genius Closes $11 Million Series A To Help Millions Conquer Addiction

Quit Genius, a personalized digital therapeutic for addiction, announced that it has raised a further $11 million in Series A funding. The round was led by Octopus Ventures, one of Europe's most active early-stage investors, with participation from Y Combinator, Startup Health, Triple Point Ventures, Serena Ventures and Venus Williams, among others. The $11 million investment will support the company's plans to expand its therapeutic programs beyond cigarette use and vaping addiction to include alcohol and substance abuse, as well as increase its presence in the U.S.

Quit Genius replaces conventional low-intensity telephonic cessation support . . .